Clinical trial

Effect of Adipokines in Hemodialysis Patients

NCT01301027

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pioglitazone Normalized identity: pioglitazoneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Adipokines in Hemodialysis Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhaseNA

Conditions

End Stage Renal Diseaseverified · MONDO: end stage renal failure

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

PlaceboDRUG

Sponsors & collaborators

University of Utahlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

University of Colorado, Denvercollaborator

Mapped research locations

DenverColorado, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01301027 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.